Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
Megadott ok: No patient eligible
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálat adatai
- Ki végzi
- Assistance Publique - Hôpitaux de Paris
- Azonosító
- NCT05649202
- A regiszteradat frissítve
- 2026. május 6.
- Eredeti leírás
Due to the high prevalence of HCV in prison and the risk of transmission between inmates, the management of hepatitis C and its treatment must be optimal following the recommendations of AFEF.A teljes eredeti leírásKevesebb
Hepatitis C in Prison: Study of Rapid Diagnosis and Treatment
Due to the high prevalence of HCV in prison and the risk of transmission between inmates, the management of hepatitis C and its treatment must be optimal following the recommendations of AFEF.
The purpose of this study is to assess the treatment starting delay from the date of incarceration of inmates with chronic HCV infection (hepatitis C).
Bevonási feltételek: Adult patient (>/= 18 years old),; Persons detained at the Paris-La Santé Penitentiary Center (CPPLS) coming from the state of freedom or transferred from another penitentiary establishment; Serology HCV positive.
Kizáró feltételek: Major psychiatric disorders with loss of discernment; Persons under guardianship or curatorship; Persons not affiliated to a social security scheme.